Patient and Healthcare Provider Perspectives on the Disease Burden of Seborrheic Dermatitis in the United States: Results From a National Survey

Main Article Content

Raj Chovatiya
Northwestern University

Lakshi Aldredge
Veterans Administration Portland Health Care System

Candrice Heath
Temple University

Moises Acevedo
Park Plaza Dermatology

David H. Chu
Arcutis Biotherapeutics

Diane Hanna
Arcutis Biotherapeutics

Melissa Seal
Arcutis Biotherapeutics

Matthew Zirwas
Dermatologists of the Central States, Probity Medical Research, and Ohio University

Keywords

Seborrheic Dermatitis, disease burden, roflumilast, phosphodiesterase 4 inhibitor

References

1. Dessinioti C, Katsambas A. Clin Dermatol 2013;31:343–351.

Article Sidebar

Poster PDF
Published
Jul 17, 2023
DOI https://doi.org/10.25251/skin.7.supp.225

Article Details

How to Cite
Chovatiya, R., Aldredge, L., Heath, C., Acevedo, M., Chu, D. H., Hanna, D., Seal, M., & Zirwas, M. (2023). Patient and Healthcare Provider Perspectives on the Disease Burden of Seborrheic Dermatitis in the United States: Results From a National Survey. SKIN The Journal of Cutaneous Medicine, 7(4), s225. https://doi.org/10.25251/skin.7.supp.225
Issue
Vol. 7 No. 4 (2023): July Issue & Posters from FCPANP 23
Section
Seborrheic Dermatitis
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Most read articles by the same author(s)

1 2 3 4 > >>